ArticleClinical & translational immunology2022

TGF-β-activated kinase-1 inhibitor LL-Z1640-2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF-α and RANKL expression.

Hirofumi Tenshin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.